Stock Scorecard



Stock Summary for Guardant Health Inc (GH) - $17.96 as of 3/28/2024 12:55:26 PM EST

Total Score

8 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for GH

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for GH

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for GH

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for GH

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for GH

REX American Resources Reports Upbeat Earnings, Joins Avalo Therapeutics, RH And Other Big Stocks Moving Higher On Thursday - REX American Resources ( NYSE:REX ) 3/28/2024 3:00:00 PM
World Molecular Diagnostics for Cancer Markets, 2023-2024 and 2027 with Profiles of Over 120 Companies 3/28/2024 10:15:00 AM
Insiders Buying Advance Auto Parts And 2 Other Stocks - Advance Auto Parts ( NYSE:AAP ) , Guardant Health ( NASDAQ:GH ) 3/20/2024 1:02:00 PM
A blood test for colon cancer performed well in a study, expanding options for screening 3/13/2024 9:14:00 PM
Metaplane Announces $13.8M Series A led by Felicis on Heels of Rapid Growth 3/5/2024 4:30:00 PM
Genetic Testing Markets - Global Market Analysis with Forecasts to 2027: Genetic Testing has Crossed the Chasm and is Now Growing in Every Area 2/26/2024 10:30:00 AM
Why Is Guardant Health Stock Trading Lower Today? - Guardant Health ( NASDAQ:GH ) 2/23/2024 6:35:00 PM
Guardant Health ( GH ) Reports Q4 Loss, Tops Revenue Estimates 2/22/2024 11:20:00 PM
Wall Street Analysts Think Guardant Health ( GH ) Could Surge 109.89%: Read This Before Placing a Bet 2/22/2024 2:55:00 PM
NeoGenomics ( NEO ) Q4 Earnings and Revenues Beat Estimates 2/20/2024 10:35:00 PM

Financial Details for GH

Company Overview

Ticker GH
Company Name Guardant Health Inc
Country USA
Description Guardant Health, Inc., a precision oncology company, offers blood testing, data sets, and testing in the United States and internationally. The company is headquartered in Redwood City, California.
Sector Name LIFE SCIENCES
Industry Name SERVICES-MEDICAL LABORATORIES
Most Recent Quarter 12/31/2023
Next Earnings Date 5/7/2024

Stock Price History

Last Day Price 17.96
Last Day Price Updated 3/28/2024 12:55:26 PM EST
Last Day Volume 2,741,839
Average Daily Volume 1,857,172
52-Week High 41.06
52-Week Low 16.91
Last Price to 52 Week Low 6.21%

Valuation Measures

Trailing PE N/A
Industry PE 261.00
Sector PE 60.76
5-Year Average PE -36.16
Free Cash Flow Ratio 1.86
Industry Free Cash Flow Ratio 16.58
Sector Free Cash Flow Ratio 31.04
Current Ratio Most Recent Quarter 6.54
Total Cash Per Share 9.67
Book Value Per Share Most Recent Quarter 1.30
Price to Book Ratio 13.14
Industry Price to Book Ratio 2.70
Sector Price to Book Ratio 21.66
Price to Sales Ratio Twelve Trailing Months 3.70
Industry Price to Sales Ratio Twelve Trailing Months 1.49
Sector Price to Sales Ratio Twelve Trailing Months 8.77

Share Statistics

Total Shares Outstanding 121,713,000
Market Capitalization 2,185,965,480
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 26.76%
Reported EPS 12 Trailing Months -4.28
Reported EPS Past Year -3.55
Reported EPS Prior Year -5.25
Net Income Twelve Trailing Months -479,449,000
Net Income Past Year -479,449,000
Net Income Prior Year -654,588,000
Quarterly Revenue Growth YOY 22.20%
5-Year Revenue Growth 44.14%

Balance Sheet

Total Cash Most Recent Quarter 1,177,234,000
Total Cash Past Year 1,177,234,000
Total Cash Prior Year 1,036,231,000
Net Cash Position Most Recent Quarter 37,268,000
Net Cash Position Past Year 37,268,000
Long Term Debt Past Year 1,139,966,000
Long Term Debt Prior Year 1,137,391,000
Total Debt Most Recent Quarter 1,139,966,000
Equity to Debt Ratio Past Year 0.12
Equity to Debt Ratio Most Recent Quarter 0.12
Total Stockholder Equity Past Year 158,684,000
Total Stockholder Equity Prior Year 60,180,000
Total Stockholder Equity Most Recent Quarter 158,684,000

Options

Put/Call Ratio 0.53
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -1.06
MACD Signal -1.05
20-Day Bollinger Lower Band 16.03
20-Day Bollinger Middle Band 22.89
20-Day Bollinger Upper Band 29.75
Beta 0.87
RSI 35.64
50-Day SMA 28.06
200-Day SMA 71.90

System

Modified 3/26/2024 8:30:04 PM EST